Latest University of Texas Stories
Once considered merely a passive link between proteins that matter, Grb2 - pronounced "grab2" - actually lives up to its nickname with its controlling grip on an important cell signaling pathway, scientists at The University of Texas MD Anderson Cancer Center report in the June 22 issue of Cell.
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet.
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting.
Breast cancer stem cells wear a cell surface protein that is part nametag and part bull's eye, identifying them as potent tumor-generating cells and flagging their vulnerability to a drug.
A genetic mutation that drives the initiation of pancreatic cancer also manipulates metabolic pathways to support tumor growth and progression.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors.
Michael Baker is an engineer and a retired United States Navy captain and NASA astronaut. He was born Michael Allen Baker on October 27, 1953 in Memphis, Tennessee, though he considers Lemoore, California to be his hometown. As a child he was active in the Boy Scouts of America. He graduated from Lemoore Union High School in 1971 and received a Bachelor of Science degree in aerospace engineering from the University of Texas in 1975. After his graduation, Baker completed flight training and...
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.